Skip to main content

Nykode Therapeutics

Nykode Therapeutics ASA is a Norwegian clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies. The company utilizes its proprietary Vaccibody technology platform to engineer targeted therapeutic vaccines for cancer indications and infectious diseases. Revenue is primarily generated through research partnerships, licensing deals, and milestone payments from international pharmaceutical collaborators. Its end markets encompass oncology and infectious disease treatment sectors within global healthcare. Nykode Therapeutics maintains a prominent position within the Nordic biotechnology sector due to its innovative modular vaccine technology platform. The company is headquartered in Oslo, Norway, and its shares are listed on the Oslo Børs stock exchange.

6 of the funds FundTelligence covers report a position in Nykode Therapeutics.

Legal name
NYKODE THERAPEUTICS ASA
Sector
Health Care
Country
Norway
Funds holding it
6

Funds holding Nykode Therapeutics

Loading...